2-异丁基环戊酮 | 4668-65-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-异丁基环戊酮
• 英文名称: 2-isobutylcyclopentanone
• 英文别名: 1-Isobutyl-cyclopentanon-2；2-(i-Butyl)-cyclopentanon；2-Isobutyl-cyclopentanon；2-Isobutylcyclopentanon；2-Iso-butylcyclopentanone；2-(2-methylpropyl)cyclopentan-1-one
• CAS: 4668-65-9
• 化学式: C₉H₁₆O
• 分子量: 140.225
• InChiKey: WDCXIPDRLFVWBC-UHFFFAOYSA-N

物化性质

• 沸点：
  84.0-84.5 °C(Press: 12 Torr)
• 密度：
  0.883 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-异丁基环戊酮 生成 2-isobutyl-2-cyclopenten-1-one
  参考文献：
  名称：

  CARDINALE, G.;LAAN, J. A. M.;RUSSELL, S. W.;WARD, J. P., REC. TRAV. CHIM. PAYS-BAS, 1982, 101, N 6, 199-202

  摘要：

  DOI：
• 作为产物：
  描述：

  5-Jod-2-isobutyl-pentannitril 在 magnesium 、 1,2-二溴乙烷 作用下， 以 乙醚 为溶剂， 生成 2-异丁基环戊酮
  参考文献：
  名称：

  镁腈腈ω-卤素的作用：环己酮合成

  摘要：

  室温下，δ-和ϵ-碘腈与镁在乙醚中反应，通过分子内环化反应生成取代的环戊酮和环己酮。

  DOI：

  10.1016/s0022-328x(00)80339-3

文献信息

• Baeyer-Villiger oxidations catalyzed by engineered microorganisms: Enantioselective synthesis of δ-valerolactones with functionalized chains
  作者：Shaozhao Wang、Gang Chen、Margaret M Kayser、Hiroaki Iwaki、Peter C.K Lau、Yoshie Hasegawa

  DOI：10.1139/v02-035

  日期：2002.6.1

  Cyclohexanone monooxygenase (CHMO) from Acinetobacter sp NCIMB 9871 expressed in baker's yeast and in E. coli and cyclopentanone monooxygenase (CPMO) from Comamonas (previously Pseudomonas) sp. NCIMB 9872 expressed in E. coli are new bioreagents for Baeyer-Villiger oxidations. These engineered microorganisms, requiring neither biochemical expertise nor equipment beyond that found in chemical laboratories

  来自不动杆菌属 NCIMB 9871 的环己酮单加氧酶 (CHMO) 在面包酵母和大肠杆菌中表达，而环戊酮单加氧酶 (CPMO) 来自毛单胞菌（以前称为假单胞菌）。在大肠杆菌中表达的 NCIMB 9872 是用于 Baeyer-Villiger 氧化的新型生物试剂。这些工程微生物既不需要生化专业知识，也不需要化学实验室以外的设备，被评估为用于环戊酮的 Baeyer-Villiger 氧化反应的试剂，环戊酮在 2 位被极性和非极性链取代，适合进一步修饰。鉴定了两种可以转化为高度对映体纯内酯的功能化底物。讨论了这些生物试剂的性能和潜力。 关键词：对映选择性 Baeyer-Villiger 氧化，生物转化，
• PREPARATION AND UTILITY OF SUBSTITUTED CARBOXYLIC ACID COMPOUNDS
  申请人：Gant Thomas G.

  公开号：US20070276042A1

  公开（公告）日：2007-11-29

  The present disclosure is directed to modulators of cyclooxygenase (COX) enzymes and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and/or management of the severity and duration of non-specific pain, tension-type pain, headache, migraine, lower back pain, sciatica, dental pain, muscular pain, pain associated with acute soft tissue injuries, bursitis, tendonitis, lumbago, periarthritis, tennis elbow, sprains, strains, muscular problems associated with sports injuries, muscular problems associated with accidents, period pain, primary dysmenorrhoea, acute sore throat pain, osteoarthritis, rheumatoid arthritis, cancer, any disorder requiring analgesic response, any disorder requiring anti-inflammatory response, any disorder requiring antipyretic response, any conditions mediated by cyclooxygenase, cystic fibrosis, dementia, Alzheimer's disease, and/or conditions mediated by levels of β-amyloid are described.

  本公开涉及环氧合酶（COX）酶的调节剂及其药用盐和前药，其化学合成，以及这些化合物的医学用途，用于治疗和/或管理非特异性疼痛、紧张性疼痛、头痛、偏头痛、腰痛、坐骨神经痛、牙痛、肌肉疼痛、急性软组织损伤引起的疼痛、滑囊炎、肌腱炎、腰痛、周围关节炎、网球肘、扭伤、拉伤、与运动损伤相关的肌肉问题、与事故相关的肌肉问题、经期疼痛、原发性痛经、急性喉咙疼痛、骨关节炎、类风湿性关节炎、癌症、需要镇痛反应的任何疾病、需要抗炎反应的任何疾病、需要退热反应的任何疾病、任何通过环氧合酶介导的病症、囊性纤维化、痴呆、阿尔茨海默病和/或通过β-淀粉样蛋白水平介导的病症。
• Process for producing 2-alkyl-2cyclopentenones
  申请人：TAKASAGO INTERNATIONAL CORPORATION

  公开号：US20030109755A1

  公开（公告）日：2003-06-12

  Industrially advantageous processes for producing a 2-alkyl-2-cyclopentenone in high yields starting from a 2-(1-hydroxyalkyl)cyclopentanone or a 2-alkylidenecyclopentanone, which are obtainable from a cyclopentanone and a carbonyl compound. A 2-(1-hydroxyalkyl)cyclopentanone represented by the following general formula (1): 1 (wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 each independently represents hydrogen atom, an alkyl group having 1 to 10 carbon atoms which may have one or more substituents or an aromatic group which may have one or more substituents, and each of (1) R 6 or R 7 with R 3 and (2) R 6 or R 7 with R 4 or R 5 may be together combined to form a ring which may have a double bond) is subjected to dehydrative isomerization in the presence of a bromine compound and/or an iodine compound.

  从环戊酮和羰基化合物获得的2-(1-羟基烷基)环戊酮或2-烷基亚烯环戊酮，是从高产率开始生产2-烷基-2-环戊酮的工业上有利的过程。在以下一般式（1）中表示的2-(1-羟基烷基)环戊酮中（其中R1、R2、R3、R4、R5、R6和R7分别独立地表示氢原子、具有1至10个碳原子的烷基基团，可能具有一个或多个取代基或可能具有一个或多个取代基的芳香基团，且(1) R6或R7与R3和(2) R6或R7与R4或R5中的每一个可能结合在一起形成可能具有双键的环)在溴化合物和/或碘化合物的存在下进行脱水异构化。
• Methods and compositions of novel triazine compounds
  申请人：Timmer T. Richard

  公开号：US20070099874A1

  公开（公告）日：2007-05-03

  The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

  本发明涉及用于治疗由炎症反应引起的病理生理状态的化合物的方法和组合物。特别地，本发明涉及抑制或阻断糖化蛋白诱导内皮细胞信号相关炎症反应的化合物。本发明涉及抑制平滑肌增殖的化合物。特别地，本发明涉及通过调节HSPG（如Perlecan）来抑制平滑肌细胞增殖的化合物。本发明进一步涉及使用化合物治疗由平滑肌增殖所特征的血管闭塞性疾病，例如再狭窄和动脉粥样硬化。
• DISUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS
  申请人：Kharul Rajendra

  公开号：US20120149704A1

  公开（公告）日：2012-06-14

  The invention relates to disubstituted benzamide derivatives of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, metabolites and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating type II diabetes using the compounds of the invention.

  本发明涉及一般式（I）的二取代苯甲酰胺衍生物、其药学上可接受的盐、药学上可接受的溶剂化物、对映体、非对映异构体、前药、代谢物和多晶形。本发明还涉及制备本发明化合物的方法、含有该化合物的制药组合物以及使用该化合物治疗II型糖尿病的方法。